trial
as of 2026-07-01Clinical Efficacy and Adverse Reactions of Antipsychotic Treatment
NCTId NCT06326840
at a glance
— · Completed
Enrollment 42 (actual)
Sponsored by Taipei Medical University Shuang Ho Hospital
Primary completion 2011-06-10
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
42 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2010-05-31
Primary completion
2011-06-10
Eligibility
ALL · 18 Years · 60 Years
Interventions & indications
Sponsors
Taipei Medical University Shuang Ho HospitalLead Sponsor
Taipei Medical University Shuang Ho HospitalCollaborator
Investigators
1
Mong-Liang Lu, MDPrincipal Investigator
Sites
1 total
Taipei, Taiwan
Facts & assertions
4 sourced
Enrollment
42
Phase
NA
Primary Completion Date
2011-06-10
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
indication
investigator
person